Press release
Insightful Developments and an Exclusive Interview from Roche
SMi are delighted to have interviewed our speaker David Silverman, Senior Clinical Director, Ophthalmology, Roche regarding his thoughts and experiences within the ophthalmology space.
Snapshot:
Q. What are the biggest developments in the ophthalmic drug industry, and how the future of ocular drug development?
Check out the full interview in the download centre
Roche’s phase III ophthalmology programme is expected to begin later in 2018
Roche announced positive, top-line results from the LADDER study, the first successful phase II study of a long-acting delivery device for the treatment of neovascular (“wet”) age-related macular degeneration (nAMD), a leading cause of blindness globally in people aged 60 and over. LADDER evaluated the efficacy and safety of the investigational Port Delivery System with ranibizumab (PDS) in people with nAMD who had previously responded to treatment with anti-vascular endothelial growth factor (VEGF) therapy. - Source: Roche.com
To hear more about the latest developments from Roche and the future phase III study, register you place today and benefit by hearing David's Keynote Address on 'Global reimbursement strategies in ophthalmic clinical development.' Download your copy of the agenda.
Network with companies such as: MHRA, Santen, Boehringer Ingelheim, Spark Therapeutics, Aerie Pharmaceuticals + more. Download the attendee list online www.ophthalmicdrugs.com/opr
For those looking to attend, there is currently a £200 early-bird saving, ending September 28th.
SMi Presents the 2nd annual:
Ophthalmic Drugs 2018
Date: 26th – 27th November 2018
Workshops: 28th November 2018
Location: Copthorne Tara Hotel, London UK
Website: www.ophthalmicdrugs.com/opr
Sponsors: Experimentica | Nemera
Source: Roche.com
Follow 'SMi Pharma' on LinkedIn for latest pharmaceutical industry updates.
---end---
Contact Information:
For all media inquiries contact Pavan Solanki on Tel: +44 (0)20 7827 6048 / Email: psolanki@smi-online.co.uk
About SMi Group:
Established since 1993, the SMi Group is a global event-production company that specializes in Business-to-Business Conferences, Workshops, Masterclasses and online Communities. We create and deliver events in the Defence, Security, Energy, Utilities, Finance and Pharmaceutical industries. We pride ourselves on having access to the world's most forward-thinking opinion leaders and visionaries, allowing us to bring our communities together to Learn, Engage, Share and Network. More information can be found at http://www.smi-online.co.uk
Westminster Bridge Road
1
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Insightful Developments and an Exclusive Interview from Roche here
News-ID: 1180965 • Views: …
More Releases from SMi Group
Exclusive Speaker Interview with AOBiome ahead of the 22nd Pain Therapeutics Con …
SMi Reports: Exclusive speaker interview with Todd Krueger at AOBiome released for the Pain Therapeutics Conference
The pain therapeutics industry has grown at an exponential rate in recent years. The 22nd Annual Pain Therapeutics conference will cover the leading advances in pain therapeutics, exploring late development clinical trials, novel treatments for chronic conditions, technology collaboration treatments, using VR and Medical Devices that carry out non-invasive nerve stimulation.
Industry leaders will uncover the…
Exclusive Speaker Interview with Ester Lovsin Barle ahead of the 6th Annual High …
Now in its 6th year, the Highly Potent Active Pharmaceutical Ingredients conference offers you peer-to-peer networking with industry experts including heads and directors of EHS, Occupational Hygiene, Quality Assurance and more. Taking place on 9th and 10th May in London, UK.
With a key focus on expanding your community and exploring the latest developments in the industry at this two-day event, including key regulatory updates, and leading case studies from leading…
FDA Keynote Speaker at SMi's 5th Annual Pharmaceutical Microbiology East Coast C …
SMi Group Reports: Keynote FDA speaker Dr. John Arigo, to present at the 4th Annual Pharmaceutical Microbiology East Coast, taking place in just 3 weeks' time on April 27th and 28th, 2022.
With just three weeks remaining until the highly anticipated conference, SMi Group are delighted to announce a key FDA Speaker joining the 5th Annual Pharmaceutical Microbiology East Coast Conference. This event will take place on April 27th and…
Group Captain (ret'd) Robert Daisley invites you to attend Air Mission Planning …
SMi Group reports: Chairman Group Captain (ret'd) Robert Daisley of the Air Mission Planning and Support Conference cordially invites experts to join the conference in London, UK in one week.
With only one week remaining, SMi Group is delighted to publish an invitation letter for SMi's 13th Annual Air Mission Planning & Support Conference, taking place on the 6th and 7th April 2022 in London, UK from the conference chairman.
The…
More Releases for Roche
Global Atezolizumab Market Future Prospects 2028 | Genentech (Roche)
"Infinity Business Insights has released a new report which examines the Global Atezolizumab Market Research Report in-depth, covering future trends, size, share, past, current data, as well as in-depth analysis and forecasts to 2022 - 2028. The report is based on studies of small and large components in the Atezolizumab market which is reflected in its broad segmentation and geographic section. The growth potential of the Atezolizumab market and its…
Tecentriq Market Analysis & Forecast 2021 - 2027|Roche, ,
Complete study of the global Tecentriq market is carried out by the analysts in this report, taking into consideration key factors like drivers, challenges, recent trends, opportunities, advancements, and competitive landscape. This report offers a clear understanding of the present as well as future scenario of the global Tecentriq industry. Research techniques like PESTLE and Porter's Five Forces analysis have been deployed by the researchers. They have also provided accurate…
PEGylated Protein Therapeutics Market Competitive Analysis | Amgen, AstraZeneca, …
PEGylated Protein Therapeutics Market analysis document helps identify the latest growths, market shares, and policies employed by the major market players. In addition, this market study affirms the leading players across the globe in the PEGylated Protein Therapeutics Market and their key marketing dispositions and advertising enterprise have been highlighted to offer a clear understanding of the market. The major topics of this document can be listed as; Overview of…
Clinical Trials Market Analysis 2020 to 2025 || Leading Players - IQVIA, Roche H …
The Global Clinical Trials Market is expected to reach USD 1.76 billion by 2025, from USD 1.04 billion in 2017 growing at a CAGR of 6.7% during the forecast period of 2018 to 2025. The upcoming market report contains data for historic year 2016, the base year of calculation is 2017 and the forecast period is 2018 to 2025..
Get Exclusive Sample Copy of This Report Here https://www.databridgemarketresearch.com/request-a-sample?dbmr=global-clinical-trials-market&raksh
Some of the major…
Global Portable Medical Electronic Equipment Market to 2025| GE Healthcare, Medt …
Portable medical electronic devices are the electronic equipment used in healthcare industry for monitoring, operating managing medical conditions.
The Portable Medical Electronic Equipment market was valued at xx Million US$ in 2018 and is projected to reach xx Million US$ by 2025, at a CAGR of xx% during the forecast period. In this study, 2018 has been considered as the base year and 2019 to 2025 as the forecast period to…
Lancet Market Built up With Top Vendors for 2022; F. Hoffmann-La Roche AG, Catal …
The Global Lancet Market is growing at an exponential rate and it is expected to grow at a CAGR of 11.3% during 2016 to 2022.
Globally, lancets are being utilized by patients who are affected by endocrine related complications, cardiovascular issues, and many others. Lancets are being used for diabetes/glucose test, tests in infants, heel-stick screening tests, as well as for scarred emergency patients or severely burned patients.
The increasing prevalence of…
